Molbio Diagnostics IPO: QIB vs retail demand swings

Molbio Diagnostics’ IPO discussions trended through August 10 to August 12 as users tracked category-wise subscription changes and compared them with Dhoot Transmission’s book.

What is trending around Molbio and Dhoot IPOs

Molbio Diagnostics’ IPO was widely discussed on Day 3 of bidding. The main theme was category-wise demand, especially QIB participation. Several posts framed it as an institutional-led book by the final day. At the same time, other updates circulating showed more moderate totals. This contrast became part of the discussion itself, with users sharing screenshots from different trackers. Dhoot Transmission also entered the conversation as a comparison point. Posts highlighted that Dhoot’s demand was led by NIIs, not QIBs. Together, both IPOs became a case study of how bids can be uneven across investor buckets.

Day 3 snapshot showing heavy institutional bids

One widely shared Day 3 update said Molbio Diagnostics was subscribed 29.13x so far on Wednesday, August 12. In that snapshot, NIIs were shown at 41.45x. Retail was shown at 10.20x. QIBs were shown at 53.19x, making them the largest contributor in that version. The same discussion thread referenced the IPO as being on its final day of bidding. Users focused on what a late QIB surge can mean for overall totals. The takeaway from that snapshot was that institutions were “leading” the book on Day 3.

Another set of live figures showing lower totals

Alongside the 29.13x snapshot, other live figures circulated with a lower overall subscription. One commonly shared table showed Molbio Diagnostics at a total subscription of 3.11x as on August 11, 07:31 PM IST. In that update, retail was at 3.184x, NIIs at 5.21x, and QIBs at 1.391x. Another table for August 12 also showed Molbio at 3.11x with similar category splits and about 6,30,274 applications. Separately, a Day 2 update said the IPO was at 2.25x overall, with QIB at 1.20x, NII at 3.35x, and retail at 2.38x. These posts suggest multiple snapshots were shared at different times during the window.

Why subscription numbers differ across posts

The most obvious reason is timing, because subscription multiples change during market hours. Several updates explicitly mention different timestamps, including August 11 evening and August 12 intraday. Another reason is that posts appear to use different data sources and formats. Some updates are “so far” numbers during the final day, while others look like scheduled refreshes. The context also includes different totals for bids and shares on offer in separate posts. For example, one post mentions 7,65,27,630 bids against 81,58,529 shares, while another mentions 24,07,08,746 bids against 2,49,56,363 shares. Without a single consolidated source in the thread, users saw inconsistent figures side by side. The practical implication is that investors should treat any single screenshot as a point-in-time snapshot.

What QIB, NII, and retail subscriptions imply

Posts repeatedly explained that subscription is total shares applied divided by shares offered. A 1x subscription means the category is fully subscribed. A 10x subscription means demand is ten times the available shares. Users also shared a simple rule-of-thumb on probabilities when subscription becomes very high. One example shared was that at 100x subscription, the theoretical chance can drop to about 1% for each applicant in that category. The context also described typical category definitions, including QIBs as institutions like mutual funds and banks. Retail was described as individuals within the usual limit (often up to Rs 2 lakh). Another post listed quota splits as retail 35%, NII 15%, and QIB 50% as SEBI-mandated allocations.

Side-by-side: Molbio vs Dhoot Transmission demand

Dhoot Transmission was discussed mainly because its QIB segment was shown as weak in the shared updates. One update said Dhoot Transmission IPO was oversubscribed 3.86x overall, but QIB remained undersubscribed at 0.49x. In the same update, Dhoot’s NII was 10.34x, employees 3.44x, and retail 2.93x. Another shared table for August 12 showed Dhoot at total 3.99x, with QIB 0.49x, NII 10.87x, and retail 3.04x. For Molbio, the table shared around the same time showed total 3.11x with QIB 1.39x, NII 5.21x, and retail 3.18x. These comparisons shaped the social narrative that NIIs were driving both, while QIB strength differed.

Grey market chatter: what was shared

GMP commentary also appeared in the same discussion threads. One post said the grey market premium (GMP) climbed to 17% from 15% earlier. Another Hindi update said Molbio Diagnostics’ GMP was trading at a premium of ₹127 on Tuesday, August 11. That post also claimed a prior one-week high of ₹220 for the GMP. It further stated an expected listing around ₹934 per share based on that ₹127 premium. The same Hindi note mentioned Dhoot Transmission GMP of ₹250 premium. These numbers were shared as market chatter, not as exchange data. Users treated GMP as a sentiment indicator rather than a certainty.

How to check IPO allotment status on NSE and BSE

Reddit and social posts repeatedly shared the steps to check allotment once available. For NSE, users were directed to the NSE IPO allotment status page. The steps shared were to choose “Equity & SME IPO bid details,” then select “Molbio Diagnostics.” Applicants were told to enter the application number and PAN. After that, clicking “Submit” shows the status. For BSE, posts pointed to the BSE allotment status page and selecting “Molbio Diagnostics” from the dropdown. Applicants could identify using PAN or application number, then complete the “I’m not a robot” check. Clicking “Search” was shown as the final step to view details.

Key takeaways for applicants tracking updates

The central takeaway from the trend was not a single subscription number, but the pace of changes and the mix across categories. Some Day 3 posts portrayed a late QIB-led surge, while other tables showed QIB closer to 1x to 1.4x. NIIs appeared consistently strong in many shared snapshots, sometimes far ahead of retail and QIB. Retail demand ranged from low single digits to double digits depending on the update being shared. Dhoot Transmission, in contrast, was repeatedly described as NII-led with QIB undersubscription in the circulated numbers. For investors, the useful habit is to check the timestamp and the source behind any figure. If tracking allotment next, the NSE and BSE portals shared in the posts are the direct way to verify status. Finally, remember that higher subscription multiples can reduce the odds of allotment in that category, as users noted with the 100x example.